Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Demyelinating Autoimmune Diseases, Central Nervous System (CNS)”

595 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 595 results

Large-scale testing (Phase 3)Study completedNCT01201356
What this trial is testing

Long-term Safety and Tolerability of 0.5 mg Fingolimod in Patients With Relapsing Forms of Multiple Sclerosis

Who this might be right for
Relapsing Forms of Multiple Sclerosis
Novartis Pharmaceuticals 4,125
Not applicableUnknownNCT05249595
What this trial is testing

Ultrasound Imaging Based Sensing of Human Ankle Motion Intent and Control Strategies for Ankle Assistance

Who this might be right for
Incomplete Spinal Cord InjuryTransverse Myelitis
North Carolina State University 25
Not applicableStudy completedNCT05757830
What this trial is testing

PURO - PUlmonary Rehabilitation With O-RAGT Platform

Who this might be right for
Multiple SclerosisSpinal Cord InjuryStroke+1 more
Fondazione Don Carlo Gnocchi Onlus 20
Early research (Phase 1)Ended earlyNCT01028209
What this trial is testing

Evaluation of [18F] PBR06 and PET as a Marker of Inflammation in Subjects With Neurological Conditions

Who this might be right for
Alzheimer DiseaseParkinson DiseaseMultiple Sclerosis
Institute for Neurodegenerative Disorders 12
Not applicableStudy completedNCT05301335
What this trial is testing

Spinal COrd NeuromodulaTor by SpIneX and ScoNE to Treat NeurogeniC BladdEr - SCONE "CONTINENCE" Clinical Study

Who this might be right for
Neurogenic BladderSpinal Cord Injuries (Complete and Incomplete)Stroke+1 more
SpineX Inc. 126
Large-scale testing (Phase 3)Study completedNCT00027300
What this trial is testing

Safety and Efficacy of Natalizumab in the Treatment of Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Biogen 900
Not applicableStudy completedNCT04266444
What this trial is testing

Functional Exercise in Virtual Environment for Persons With Multiple Sclerosis or Parkinson's Disease

Who this might be right for
Parkinson DiseaseMultiple Sclerosis
University Rehabilitation Institute, Republic of Slovenia 108
Not applicableStudy completedNCT04158063
What this trial is testing

Cognitive-motor Interference in Persons With MS

Who this might be right for
Multiple Sclerosis
Hasselt University 112
Large-scale testing (Phase 3)Study completedNCT02003144
What this trial is testing

An Open Label Extension Trial of Eculizumab in Relapsing NMO Patients

Who this might be right for
Neuromyelitis OpticaNeuromyelitis Optica Spectrum Disorder
Alexion Pharmaceuticals, Inc. 119
Not applicableWithdrawnNCT01453764
What this trial is testing

Study to Assess the Safety and Effects of Autologous Adipose-Derived Stromal Cells Delivered Into Patients With Multiple Sclerosis

Who this might be right for
Multiple SclerosisAutoimmune DiseasesAutoimmune Diseases of the Nervous System+1 more
Ageless Regenerative Institute
Large-scale testing (Phase 3)Study completedNCT04626921
What this trial is testing

A Multi-Center, Open-Label Long-Term Extension Study of CNM-Au8 In Patients With Stable Relapsing Multiple Sclerosis

Who this might be right for
Relapsing Multiple Sclerosis
Clene Nanomedicine 55
Not applicableStudy completedNCT01414725
What this trial is testing

Core Stability Training in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
University of Plymouth 100
Not applicableUnknownNCT06055998
What this trial is testing

Frequency ,Etiology and Prognostic Factors of Acute Transverse Myelitis

Who this might be right for
Transverse Myelitis
Assiut University 50
Testing effectiveness (Phase 2)Study completedNCT00879658
What this trial is testing

Safety, Tolerability, Efficacy and Optimal Dose Finding Study of BAF312 in Patients With Relapsing-remitting Multiple Sclerosis

Who this might be right for
Relapsing-remitting Multiple Sclerosis
Novartis Pharmaceuticals 297
Not applicableActive Not RecruitingNCT07456475
What this trial is testing

Metaverse Applications in Clinical Neurorehabiliation: Device Feasibility

Who this might be right for
Neurological DisorderMultiple SclerosisParkinson Disease+2 more
Istituto per la Ricerca e l'Innovazione Biomedica 25
Not applicableStudy completedNCT01399957
What this trial is testing

Responsiveness to Dalfampridine-ER Treatment Among Multiple Sclerosis Patients

Who this might be right for
Multiple Sclerosis
Mount Sinai Rehabilitation Hospital 52
Not applicableStudy completedNCT02339675
What this trial is testing

Psychometric Properties Upper Limb Function Measures Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Hasselt University 136
Not applicableEnded earlyNCT00398528
What this trial is testing

An fMRI Study of Treatment Optimization Comparing Two Disease Modifying Therapies Used to Treat Relapsing Remitting Multiple Sclerosis

Who this might be right for
Relapsing-Remitting Multiple Sclerosis
Neurognostics 48
Not applicableStudy completedNCT06251830
What this trial is testing

Increasing Diagnosis Rates While Reducing Examination Time: Can MR Fingerprinting Deliver on Its Promise?

Who this might be right for
Neurodevelopmental DisordersNeurodegenerative DiseasesBrain Tumor+2 more
IRCCS Fondazione Stella Maris 610
Not applicableLooking for participantsNCT06450418
What this trial is testing

Digital App for Speech & Health Monitoring

Who this might be right for
DementiaMotor Neuron DiseaseMultiple Sclerosis+1 more
University of Edinburgh 150
Load More Results